Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Eucomed challenges "irrational" national decisions:

This article was originally published in Clinica

Executive Summary

Six issues that have been identified as priorities by the Eucomed Legal Issues Group for 2005 include challenging irrational national reimbursement decisions as well as continuing scrutiny and understanding of national procurement practices. These reflect the mounting obstacles that industry still faces despite regulatory convergence. The other four issues are: late payments and what can be learnt from the Spanish and Italian approaches; new technologies - the need for appropriate regulatory mechanisms to avoid the inevitable drift towards inappropriate and expensive pharma-based systems; strategic future of regulation - reform of the Medical Devices Directive and related legislation; and analysis of the implications of EU horizontal measures.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts